Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62nd American Society of Hematology virtual annual meeting ASH, December 6, 2020. See presentation below.
Oncopeptides presented new data from phase 2 ANCHOR combination study in multiple myeloma the 62nd American Society of Hematology virtual annual meeting ASH, December 6, 2020. See presentation below.
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com